Related Experiment Video
Updated: Aug 18, 2026

Rescue of Recombinant Newcastle Disease Virus from cDNA
Published on: October 11, 2013
Intranuclear degradation of the transformation-inducing protein encoded by avian MC29 virus
Abstract:
The nuclear protein, p110, encoded by the avian MC29 virus degrades with a half-life of 30 to 40 min in virus-transformed cells. Inhibitors of lysosomal proteolysis had no effect on this degradation. When inhibitors of RNA or protein synthesis were added immediately after pulse-labeling the p110 with [35S]methionine, degradation was impeded. Treatment of cells with cycloheximide prior to, and after, the pulse extended the half-life of p110 further than post-treatment alone, and addition of both actinomycin D and cycloheximide to cells pretreated with cycloheximide extended the half-life even further. In cells depleted of cellular ATP using a glucose-deficient medium containing oligomycin, degradation of p110 was only partially inhibited, indicating no direct involvement of ATP in degradation. Isolation of nuclei or nuclear matrices containing labeled p110, with subsequent incubation, resulted in minimal loss of p110 during several hours. These results suggest that p110 is degraded by a protease which is itself labile and freely diffusible from the nucleus, and, in addition, degradation may involve interaction of p110 with newly synthesized RNA.
Insights
The avian MC29 virus
Area of Science:
- Molecular biology
- Virology
- Cellular biology
Background:
- The avian MC29 virus encodes a nuclear protein, p110.
- Understanding the degradation pathway of viral proteins is crucial for comprehending viral pathogenesis.
Purpose of the Study:
- To investigate the degradation mechanism of the nuclear protein p110 in virus-transformed cells.
- To identify factors influencing the stability and turnover of p110.
Main Methods:
- Pulse-chase labeling with [35S]methionine to track p110 protein.
- Treatment with inhibitors of lysosomal proteolysis, RNA synthesis (actinomycin D), and protein synthesis (cycloheximide).
- Assessment of p110 degradation in ATP-depleted cells and isolated nuclear fractions.
Main Results:
- p110 protein exhibits rapid degradation with a half-life of 30-40 minutes.
- Lysosomal proteolysis inhibitors did not affect p110 degradation.
- Inhibition of RNA or protein synthesis significantly impeded p110 degradation.
- Cycloheximide and actinomycin D treatments extended p110 half-life.
- ATP depletion only partially inhibited degradation, suggesting no direct ATP involvement.
- Minimal p110 loss was observed in isolated nuclei, indicating nuclear localization of degradation factors.
Conclusions:
- p110 degradation is mediated by a labile, nuclear-diffusible protease.
- Degradation may involve interactions with newly synthesized RNA.
- The findings suggest a unique protein turnover mechanism for viral nuclear proteins.
Related Concept Videos
Retrovirus Life Cycles
Viral Mutations
Nuclear Export of mRNA
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Leaky Scanning
Subviral Agents

